BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15078134)

  • 61. Molecular therapeutic approaches for pediatric acute myeloid leukemia.
    Tasian SK; Pollard JA; Aplenc R
    Front Oncol; 2014; 4():55. PubMed ID: 24672775
    [TBL] [Abstract][Full Text] [Related]  

  • 62. FLT3 inhibition as therapy in acute myeloid leukemia: a record of trials and tribulations.
    Fathi AT; Chabner BA
    Oncologist; 2011; 16(8):1162-74. PubMed ID: 21765192
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Exploiting signal transduction pathways in acute myelogenous leukemia.
    Perl AE; Carroll M
    Curr Treat Options Oncol; 2007 Aug; 8(4):265-76. PubMed ID: 18097642
    [TBL] [Abstract][Full Text] [Related]  

  • 64. FLT3 antibody-based therapeutics for leukemia therapy.
    Li Y; Zhu Z
    Int J Hematol; 2005 Aug; 82(2):108-14. PubMed ID: 16146840
    [TBL] [Abstract][Full Text] [Related]  

  • 65. FLT3 tyrosine kinase inhibitors.
    Levis M; Small D
    Int J Hematol; 2005 Aug; 82(2):100-7. PubMed ID: 16146839
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Autologous stem cell transplantation in hematological malignancies.
    Gorin NC
    Springer Semin Immunopathol; 2004 Nov; 26(1-2):3-30. PubMed ID: 15480668
    [No Abstract]   [Full Text] [Related]  

  • 67. Targeting FLT3 kinase in acute myelogenous leukemia: progress, perils, and prospects.
    Heinrich MC
    Mini Rev Med Chem; 2004 Mar; 4(3):255-71. PubMed ID: 15032673
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Therapeutic intervention in leukemias that express the activated fms-like tyrosine kinase 3 (FLT3): opportunities and challenges.
    Sternberg DW; Licht JD
    Curr Opin Hematol; 2005 Jan; 12(1):7-13. PubMed ID: 15604885
    [TBL] [Abstract][Full Text] [Related]  

  • 69. FLT3 Inhibitors in the Treatment of AML.
    Gilliland DG
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):708-10. PubMed ID: 16163256
    [No Abstract]   [Full Text] [Related]  

  • 70. FLT3 tyrosine kinase as a target in acute leukemias.
    Griffin JD
    Hematol J; 2004; 5 Suppl 3():S188-90. PubMed ID: 15190306
    [No Abstract]   [Full Text] [Related]  

  • 71. Small molecule FLT3 tyrosine kinase inhibitors.
    Levis M; Small D
    Curr Pharm Des; 2004; 10(11):1183-93. PubMed ID: 15078134
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Novel FLT3 tyrosine kinase inhibitors.
    Levis M; Small D
    Expert Opin Investig Drugs; 2003 Dec; 12(12):1951-62. PubMed ID: 14640939
    [TBL] [Abstract][Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.